NCT04185922View on ClinicalTrials.gov

Hemopatch to Prevent Lymphatic Leak After Robotic Prostatectomy and Pelvic Lymph Node Dissection

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 27, 2020

Primary Completion Date

July 21, 2021

Study Completion Date

June 10, 2022

Conditions
Prostate Cancer
Interventions
DEVICE

Hemopatch

As stated in Hemopatch arm description

Trial Locations (1)

Unknown

Prince of Wales Hospital, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT04185922 - Hemopatch to Prevent Lymphatic Leak After Robotic Prostatectomy and Pelvic Lymph Node Dissection | Biotech Hunter | Biotech Hunter